Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 456 (4), 449-54

The Role of the Pathologist in Tissue Banking: European Consensus Expert Group Report

Affiliations
Review

The Role of the Pathologist in Tissue Banking: European Consensus Expert Group Report

Generoso Bevilacqua et al. Virchows Arch.

Abstract

Human tissue biobanking encompasses a wide range of activities and study designs and is critical for application of a wide range of new technologies (-"omics") to the discovery of molecular patterns of disease and for implementation of novel biomarkers into clinical trials. Pathology is the cornerstone of hospital-based tissue biobanking. Pathologists not only provide essential information identifying the specimen but also make decisions on what should be biobanked, making sure that the timing of all operations is consistent with both the requirements of clinical diagnosis and the optimal preservation of biological products. This document summarizes the conclusions of a Pathology Expert Group Meeting within the European Biological and Biomolecular Research Infrastructure (BBMRI) Program. These recommendations are aimed at providing guidance for pathologists as well as for institutions hosting biobanks on how to better integrate and support pathological activities within the framework of biobanks that fulfill international standards.

Similar articles

See all similar articles

Cited by 22 articles

See all "Cited by" articles

References

    1. Riegman PH, Dinjens WN, Oosterhuis JW. Biobanking for interdisciplinary clinical research. Pathobiology. 2007;74:239–244. doi: 10.1159/000104451. - DOI - PubMed
    1. Riegman PH, Morente MM, Betsou F, et al. Biobanking for better healthcare. Mol Oncol. 2008;2:213–222. doi: 10.1016/j.molonc.2008.07.004. - DOI - PMC - PubMed
    1. Morente MM, Fernandez PL, Alava E. Biobanking: old activity or young discipline? Semin Diagn Pathol. 2008;25:317–322. doi: 10.1053/j.semdp.2008.07.007. - DOI - PubMed
    1. Asslaber M, Zatloukal K. Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic. 2007;6:193–201. doi: 10.1093/bfgp/elm023. - DOI - PubMed
    1. Pukkala E, Andersen A, Berglund G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control–more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol. 2007;46:286–307. doi: 10.1080/02841860701203545. - DOI - PubMed

Publication types

LinkOut - more resources

Feedback